CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual).

Autor:	Joh HS; International Vaccine Institute, Seoul, Republic of Korea., Dolabella B; Public Health Surveillance Group, LLC, Princeton, New Jersey, USA., Early E; International Vaccine Institute, Seoul, Republic of Korea., Stelling J; Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ak G; Port Moresby General Hospital, Port Moresby, Papua New Guinea., Upadhyaya MK; Ministry of Health and Population, Kathmandu, Nepal., Rahman A; Communicable Disease Control, Directorate General of Health Services, Ministry of Health and Family Welfare, Dhaka, Bangladesh., Chuki P; Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan., MacWright WR; Public Health Surveillance Group, LLC, Princeton, New Jersey, USA., Ondoa P; African Society for Laboratory Medicine, Addis Ababa, Ethiopia.; Department of Global Health, Amsterdam Institute for Global health and Development, University of Amsterdam, Amsterdam, The Netherlands., Sarkar S; International Vaccine Institute, Seoul, Republic of Korea., Moore C; Institute of Infection and Immunity at St George's, University of London, London, United Kingdom., Holm M; International Vaccine Institute, Seoul, Republic of Korea., Leslie T; Fleming Fund Management Agent, Mott MacDonald, London, United Kingdom., Zellweger RM; International Vaccine Institute, Seoul, Republic of Korea., Paing G; International Vaccine Institute, Seoul, Republic of Korea., Kwon SY; International Vaccine Institute, Seoul, Republic of Korea., Marks F; International Vaccine Institute, Seoul, Republic of Korea.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Poudyal N; International Vaccine Institute, Seoul, Republic of Korea.
Jazyk:	angličtina
Zdroj:	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Dec 20; Vol. 77 (Suppl 7), pp. S536-S542.
DOI:	10.1093/cid/ciad568
Abstrakt:	In response to the global threat of antimicrobial resistance (AMR), the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project worked with microbiology laboratories, pharmacies, and local governments in South Asia and Southeast Asia to expand the volume of historical and current data available on AMR and antimicrobial use and to identify gaps in data and areas for quality improvement. When the CAPTURA project completed its country-level engagement in the first half of 2022, the consortium brought together local, regional, and global AMR stakeholders for a virtual regional workshop to review data outputs from the project and share strategies to inform national and regional efforts to combat AMR. This paper summarizes the main topics presented in the workshop held from 28 to 30 June 2022. As such, it highlights lessons learned from the project and strategies to fight AMR. Although CAPTURA has been invaluable to countries and information from the project is already being used, barriers concerning data quality and sharing remain. Regional-level initiatives should continue to build on the momentum gained from the CAPTURA project in supporting national-level surveillance and data quality improvements to inform critical decisions around planning, policies, and clinical care. Project findings have highlighted that issues with antimicrobial resistance and use are wide ranging across countries. Going forward, building on the current foundations and tailoring approaches to meet local needs and capacities will be fundamental in combatting AMR. Competing Interests: Potential conflicts of interest. T. L. reports funding from Mott McDonald Ltd and the Fleming Fund. P. O. reports that part of their salary is provided by The Fleming Fund. E. E. reports being a consultant with the International Vaccine Institute since April 2021 and staff and consulting funds from the WHO WPRO, ABD, FHI, and UNICEF. J. S. reports a subcontract for salary support and travel from the International Vaccine Institute. B. D. reports compensation from the Public Health Surveillance Group. W. M. reports a subgrant for the CAPTURA project from the International Vaccine Institute and is a grantee of UKaid. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu